Neurogenic

Develops sensitive immunoassays to facilitate the diagnosis of mental disorders.

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
Neurogenic
02/09/2022
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Biochemical: pharmacological drugs (Developing drugs)
01/01/1995
"1-10"

Neurogenic is a clinical-stage diagnostics company that develops sensitive immunoassays to facilitate the diagnosis of mental disorders. The company has developed a straightforward, highly sensitive, and specific blood test for the diagnosis of schizophrenia in children with behavioral disorders.